Update on Psoriasis: Biologics, Biosimilars and Beyond
Faculty: Cory Rubin, MD, FAAD
With so many treatment options for psoriatic disease, and many more coming — how do you make sense of them? In this podcast, Cory Rubin, MD, FAAD, discusses the current landscape and future options in a practical way.
Highlights of the Podcast:
- Learn about the currently approved biologics for PsO/PsA—MOA, dosing, molecular design, etc.
- Discussions on biosimilars with regard to how they are developed and the differences between “biosimilars” and “generics”.
- A look at future treatments in the pipeline to include—biologics, small molecules, and others.
Understand why psoriasis is a chronic illness that poses a threat to life and bodily function